Literature DB >> 3090586

Behavioural tolerance to arecoline in rats: cross-tolerance to oxotremorine and prevention by pretreatment with atropine.

D H Overstreet, O S Jamal.   

Abstract

In two experiments tolerance development to the effects of arecoline on operant responding for a water reward was shown to be dose-dependent, complete tolerance developing to a daily dose of 4 mg/kg, but only partial tolerance developing to a daily dose of 8 mg/kg. However, rats chronically treated with the higher dose of arecoline were least affected by a challenge dose of oxotremorine (0.2 mg/kg); i.e. the high dose group exhibited the greatest cross-tolerance to oxotremorine. Moreover, atropine (4 mg/kg) pretreatment prior to arecoline (4 mg/kg) prevented cross-tolerance to oxotremorine, indicating that dispositional mechanisms are unlikely to be involved in tolerance to arecoline.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090586     DOI: 10.1007/bf00175202

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Behavioral effects of arecoline in rats.

Authors:  S N Pradhan; S N Dutta
Journal:  Psychopharmacologia       Date:  1970

2.  Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.

Authors:  R E Harbaugh; D W Roberts; D W Coombs; R L Saunders; T M Reeder
Journal:  Neurosurgery       Date:  1984-10       Impact factor: 4.654

3.  Tolerance to the disruptive effects of arecoline on schedule-controlled behavior.

Authors:  L T Meltzer; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Memory retention test performance in mice: improvement by chronic oral cholinergic drug treatment.

Authors:  J F Flood; G E Smith; A Cherkin
Journal:  Pharmacol Biochem Behav       Date:  1984-07       Impact factor: 3.533

5.  Human serial learning: enhancement with arecholine and choline impairment with scopolamine.

Authors:  N Sitaram; H Weingartner; J C Gillin
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

6.  Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic.

Authors:  R Majocha; R J Baldessarini
Journal:  Life Sci       Date:  1984-11-26       Impact factor: 5.037

7.  Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists.

Authors:  D H Overstreet; R W Russell
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics.

Authors:  R T Bartus; R L Dean; B Beer
Journal:  Neurobiol Aging       Date:  1980       Impact factor: 4.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.